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Abstract
Homozygosity disequilibrium (HD), a nonrandom sizable run of homozygosity in the genome, may be related to
the evolution of populations and may also confer susceptibility to disease. No studies have investigated HD using
whole genome sequencing (WGS) analysis. In this study, we used an enhanced version of Loss-Of-Heterozygosity
Analysis Suite (LOHAS) software to investigate HD through analysis of real and simulated WGS data sets provided
by Genetic Analysis Workshop 18. Using a local polynomial model, we derived whole-genome profiles of
homozygosity intensities for 959 individuals and characterized the patterns of HD. Generalized estimating equation
analysis for 855 related samples was performed to examine the association between patterns of HD and 3
phenotypes of interest, namely diastolic blood pressure, systolic blood pressure, and hypertension status, with
covariate adjustments for age and gender. We found that 4.48% of individuals in this study carried sizable runs of
homozygosity (ROHs). Distributions of the length of ROHs were derived and revealed a familial aggregation of HD.
Genome-wide homozygosity association analysis identified 5 and 3 ROHs associated with diastolic blood pressure
and hypertension, respectively. These regions contain genes associated with calcium channels (CACNA1S), renin
catalysis (REN), blood groups (ABO), apolipoprotein (APOA5), and cardiovascular diseases (RASGRP1). Simulation
studies showed that our homozygosity association tests controlled type 1 error well and had a promising power.
This study provides a useful analysis tool for studying HD and allows us to gain a deeper understanding of HD in
the human genome.
Background
Homozygosity disequilibrium (HD) describes a phenom-
enon in which a nonrandom pattern is observed for a siz-
able run of homozygosity (ROH) in the human genome,
where ROH indicates a contiguous set of homozygous
genotypes in an intact genomic region or allows to be
interrupted by a small proportion of heterozygous geno-
types arising from genotyping errors, missing genotypes,
or mutations [1]. HD can result from autozygosity [2],
natural selection [3], and chromosomal aberrations [4].
Previous studies suggested that HD may confer suscept-
ibility to neurodevelopment-related disorders [5,6] and
autoimmune diseases [1,7]. No studies have investigated
HD with whole genome sequencing (WGS) analysis. This
study analyzed a real human WGS data set and simulated
data sets provided by Genetic Analysis Workshop 18
(GAW18) with four major aims. The first aim was to
develop statistical methods and analysis tools to examine
HD in WGS data. The second aim was to characterize
patterns of HD in the human genome. The third aim was
to identify regions of HD associated with diastolic blood
pressure (DBP), systolic blood pressure (SBP), and hyper-
tension status. The final aim of this study was to evaluate
the performance of the proposed genome-wide homozyg-
osity association analysis approach on the simulated data
set. This study constitutes a useful resource for examin-
ing HD and provides insight into the potential roles of
HD in population genetics and medical genetics.
Methods
Materials
GAW18 provided a combined imputation data set derived
from deep sequencing data for the whole genomes of 464* Correspondence: hsinchou@stat.sinica.edu.tw
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individuals and genome-wide association genotype data
for 495 individuals. All 959 individuals were from 20 large
independent pedigrees enrolled in the T2D-GENES (Type
2 Diabetes Genetic Exploration by Next-generation
sequencing in Ethnic Samples) Project 2. Full information
about blood pressures (DBP and SBP) and covariates (age
and gender) was also available for 855 of these individuals.
In this study, an individual was considered hypertensive if
he or she had ever taken antihypertensive medication or
his or her DBP was greater than 90 mm Hg or SBP was
greater than 140 mm Hg at the most recent examination.
The genome of each individual was sequenced by
Complete Genomics with an average depth of coverage of
60x. Multiple quality control procedures were carried out
to filter out single-nucleotide variants (SNVs) with poor
performance in allele balance, strand bias, fraction of bases
with low quality, and Mendelian errors by GAW18. The
WGS data set of 464 individuals contained 24 million of
SNVs that passed quality filters, and more than 51% of
them were rare variants (RVs). The combined data set of
959 individuals contained 8,348,663 single-nucleotide
polymorphisms (SNPs) and 5,573,886 RVs for odd-
numbered autosomes. In addition, GAW18 provided 200
simulation data sets of quantitative trait Q1. Q1 was gen-
erated from a normal distribution and was independent of
genetic variants in this study.
Statistical methods
For this study, we developed an enhanced version of the
Loss-Of-Heterozygosity Analysis Suite (LOHAS) soft-
ware [8]. LOHAS was originally developed for detecting
loss of heterozygosity in cancer research and identifying
long contiguous stretches of homozygosity in population
genetics studies using SNP genotype data. LOHAS pro-
vides a two-step procedure for homozygosity association
studies. First, LOHAS constructs sliding windows on a
chromosome using a nearest neighbor method and esti-
mates homozygosity intensity in each window for each
individual using a local polynomial model. In the model,
the homozygote-heterozygote status was regressed by
the physical positions of SNVs to calculate the homo-
zygosity intensity. Homozygosity intensities are values
between 0 and 1. Second, LOHAS performs a linear-
rank association test to identify runs of homozygosity
(ROHs) with differential homozygosity intensities
between the study groups.
We extended LOHAS to handle large numbers of SNPs
and RVs in the WGS data by introducing the following
adapted coding system of homozygote-heterozygote status.
Major and minor alleles at a SNV were denoted A and a,
respectively. SNVs were classified as SNPs if their minor
allele frequency (MAF) was higher than 0.05 or as RVs if
lower than 0.05, where MAF was calculated across the
whole population. For the SNP analysis, the coding system
was the same as that used in the original LOHAS software.
Homozygotes (aa and AA) were coded as 1 and heterozy-
gotes (Aa) as 0. For the RV analysis, rare homozygotes
(aa) and heterozygotes (Aa) were coded as 1 and 0,
respectively. Because common homozygotes (AA) of RVs
are less informative and therefore could dilute the assess-
ment of other informative homozygotes when defining
ROH, they were analyzed separately. Homozygosity
intensity of a window anchored at a common homozy-
gote of a RV was estimated by inputting the physical
position of the anchor into the fitted local polynomial
model, which was built based on genotypes except for
common homozygotes of RVs. We also expanded
LOHAS software by adding model-based methods for
studying a dichotomous or quantitative trait with or
without an adjustment for covariates. A new analysis
module of generalized estimating equation (GEE) was
included for analysis of related individuals, and a new
analysis module of linear regression model was included
for analysis of unrelated individuals.
To estimate whole-genome homozygosity intensities of
all 959 individuals, a window size, 5% of SNVs on a chro-
mosome, was considered. Each window contained 11,968
to 65,465 SNVs. The GEE was used to analyze 855
related samples with WGS data, blood pressures, hyper-
tension status, and covariates. Homozygosity intensities
were modeled as a continuous response to correlate with
DBP values, SBP values, and hypertension status, with
concomitant adjustment for age and gender.
We also evaluated type 1 error and test power of the
homozygosity association tests using simulation data.
Type 1 error was analyzed by examining the association
between homozygosity intensities and Q1 (with covariate
adjustments for age and gender) using the GEE analysis.
We calculated the proportion of times that the null
hypothesis was rejected over 200 simulations at each win-
dow and then calculated the average type 1 error over all
windows. Test power was analyzed by choosing 3 regions
on chromosome 21 containing 200 SNVs for each with
varying proportions of RVs. The 3 regions contained
51.5%, 66.5%, and 80.0% RVs representing the 10th, 50th,
and 90th percentiles of proportions of RVs on chromo-
some 21, respectively. The 3 regions were designated as
Q1-associated ROHs by a logistic regression model as
follows:
Logit(p) = b0 + b1 · Q1,
where p is the probability that all genotypes in the
region were replaced by homozygotes and b0 and b1 are
the regression coefficients. The test power was calculated
as the proportion of times that the null hypothesis was
rejected over 200 simulations at a Q1-associated ROH.
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Results
Our analyses were performed without knowledge of the
underlying simulation model. Whole-genome profiles of
homozygosity intensities for 959 individuals were
derived from the GAW18 data set. Approximately 4.48%
of individuals (43/959) carried sizable ROHs with homo-
zygosity intensities greater than 0.9 and run lengths
greater than 5 Mb. The minimum, 25th, 50th, and 75th
percentiles and maximum of ROH lengths were 5.07, 5.66,
7.40, 13.61, and 44.60 Mb, respectively. The minimum,
25th, 50th, and 75th percentiles and maximum of total
lengths of ROHs carried by an individual were 5.07, 5.64,
7.54, 14.81, and 105.85 Mb, respectively. Figure 1 shows
an example of a male subject (T2DG0300128) who carries
multiple ROHs on chromosomes 1, 5, 9, 11, 13, 15, and
19. We also observed a familial aggregation of ROHs. For
example, four individuals (T2DG2701096, T2DG2701097,
T2DG2701098, and T2DG2701099) in pedigree 27 carried
the identical ROHs on chromosomes 13 and 21.
We carried out whole-genome homozygosity tests to
identify DBP-, SBP-, or hypertension-associated ROHs.
GEE analysis of 855 related individuals identified several
DBP- or hypertension-associated ROHs after controlling
for false discovery rate (Figure 2). DBP-associated ROHs
were located in the regions ranged from 198.4 to 210.0
Mb on chromosome 1 (adjusted p-value = 0.0396), from
31.9 to 38.1 Mb on chromosome 9 (adjusted p-value =
0.0396), from 41.4 to 48.5 Mb (adjusted p-value = 0.0396)
and from 97.7 to 103.3 Mb (adjusted p-value = 0.0396) on
chromosome 11, and from 108.0 to 112.1 Mb on chromo-
some 13 (adjusted p-value = 0.0396). Hypertension-
associated ROHs were located in the regions ranged from
132.7 to 137.9 Mb on chromosome 9 (adjusted p-value =
0.0264), from 109.5 to 116.1 Mb on chromosome 11
(adjusted p-value = 0.0050), and from 33.7 to 37.5 Mb on
chromosome 15 (adjusted p-value = 0.0050). No SBP-
associated ROHs were found.
We evaluated type 1 error of the homozygosity associa-
tion tests by analyzing 200 simulation data sets of quanti-
tative trait Q1. For a GEE association analysis of the 855
related individuals, the mean of type 1 errors was 0.03.
We also evaluated the test power of our homozygosity
association tests by analyzing the 200 simulation data sets
with 3 Q1-associated ROHs created under the parameters
that b0 = −20 and b1 = 0.5 in our simulation model. For
the GEE analysis of 855 related individuals, the power for
the 3 Q1-associated ROHs containing 51.5%, 66.5%, and
80.0% RVs was 1.00, 1.00, and 1.00, respectively. The
power was reduced to 0.910, 0.975, and 0.945 when
b0 = −20 was changed to b0 = −10.
Figure 1 Whole-genome profiling of homozygosity intensity on odd-numbered chromosomes for subject T2DG0300128 in pedigree 3.
We used a window size of 5% of single-nucleotide variants (SNVs) on each chromosome. The homozygosity intensity curve of a male individual
is shown. Each vertical axis represents homozygosity intensity from 0 to 1, and each horizontal axis represents the physical positions (Mb) of
anchor SNVs of the runs of homozygosity.
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Discussion and conclusions
This study has made several contributions to WGS data
analysis of HD in the human genome. First, we adapted
LOHAS software to enable more complete analysis of
WGS data for HD. Two new homozygosity association
analysis modules, a regression-based analysis for unrelated
individuals and a GEE-based analysis for related indivi-
duals, have been incorporated into LOHAS. Software,
examples, and user guide are now available free of charge
at http://www.stat.sinica.edu.tw/hsinchou/genetics/loh/
LOHAS.htm.
Second, we characterized the patterns of HD by analyz-
ing a large WGS data set of 959 individuals from 20 ped-
igrees. The distribution of lengths for sizable ROHs and a
distribution of total run length for one individual were
obtained. The larger individual total run lengths of an
individual may suggest autozygosity owing to inbreeding,
consanguineous marriage, or a recent common ancestor.
This approach may also be useful in identifying specific
types of chromosomal aberrations such as uniparental
disomy, hemizygous deletion, and loss of heterozygosity
in cancer studies. In addition, we found that patterns of
HD differ among individuals. We also observed familial
aggregation, suggesting a genetic component of HD.
A sensitivity analysis, which considered 3 thresholds of
MAF for defining RVs (MAF = 0.04, 0.05, and 0.06),
showed that the results were robust to a small change in
the threshold of MAF for defining RVs. These findings
suggest potential applications of these methods in genetic
studies.
Third, our GEE-based homozygosity association tests
identified 5 DBP-associated ROHs and 3 hypertension-
associated ROHs. Genes in these ROHs include some that
are associated with calcium channels, renin catalysis, insu-
lin-like growth factor (IGF), blood groups, apolipoprotein,
cardiovascular diseases, and rat sarcoma. Specifically,
within the DBP-associated ROHs, two genes on chromo-
some 1q32 encode proteins that inactivate calcium chan-
nels in skeletal muscle cells (CACNA1S) and play a role in
renin catalysis (REN), both of which are important for the
regulation of blood pressure. IGFBPL1 on 9p13.1 encodes
IGF binding protein. Within the hypertension-associated
ROHs, ABO on 9q34.2 is associated with the ABO blood
group system. APOA1, APOA4, APOA5, and APOC3 on
11q23-q24 encode apolipoproteins and have been asso-
ciated with cardiovascular diseases. RASGRP1 on 15q14
encodes a protein that functions as a Ras activator as well
as a switch that is regulated by calcium and diacylglycerol,
and guanosine triphosphate-guanosine diphosphate
exchange. However, these results are still preliminary, and
Figure 2 Examination of the association between homozygosity intensities on odd-numbered chromosomes and 3 phenotypes of
interest. We used a window size of 5% of single-nucleotide variants (SNVs) on each chromosome. Homozygosity association tests for diastolic
blood pressure (DBP) (red line), systolic blood pressure (SBP) (blue line), and hypertension (HTN) status (green line) are shown. Each vertical axis
represents the raw p-values (-log10 scale) of the association tests (generalized estimating equation model), and each horizontal axis represents
the physical positions (Mb) of anchor SNVs of runs of homozygosity. The arrows point to p-values that were significant after controlling for false
discovery rate.
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the findings should be further investigated in future
studies.
We also examined homozygosity associations of 142
samples from unrelated individuals (85 hypertensive cases
and 57 normotensive control participants) using a linear
regression analysis. However, probably owing to the rela-
tively small number of samples, none of the ROHs in this
analysis was found to be associated with DBP, SBP, or
hypertension after controlling for false discovery rate.
In summary, the enhanced LOHAS developed in this
study represents a useful tool for studying HD under
different ascertainment schemes (unrelated and related
individuals), phenotypes of interest (dichotomous dis-
ease status and quantitative traits), and experimental
platforms (SNP microarrays and next-generation
sequencing experiments). Performance of the improved
LOHAS homozygosity association tests was evaluated by
simulation studies, and the results suggest that the
methods are reliable with a high test power and well-
controlled type 1 error. Additional simulation studies
and real data analyses will further elucidate the limita-
tions of our methods and helps us further understand
HD in the human genome.
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